Vistagen Therapeutics SG&A Expense (Quarterly) Insights

Vistagen Therapeutics Inc (VTGN)

4.08 -0.02 (-0.49%) USD | NASDAQ | May 24, 16:00

4.07 -0.01 (-0.25%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2007. Upgrade now.

Date	Value
December 31, 2023	3.758M
September 30, 2023	3.207M
June 30, 2023	2.978M
March 31, 2023	3.078M
December 31, 2022	3.092M
September 30, 2022	3.702M
June 30, 2022	4.792M
March 31, 2022	4.498M
December 31, 2021	3.118M
September 30, 2021	3.221M
June 30, 2021	2.411M
March 31, 2021	2.321M
December 31, 2020	2.117M
September 30, 2020	1.27M
June 30, 2020	1.391M
March 31, 2020	1.423M
December 31, 2019	2.121M
September 30, 2019	1.146M
June 30, 2019	1.91M
March 31, 2019	1.964M
December 31, 2018	1.831M
September 30, 2018	2.171M
June 30, 2018	1.466M
March 31, 2018	2.763M
December 31, 2017	0.9883M

Date	Value
September 30, 2017	2.287M
June 30, 2017	1.165M
March 31, 2017	1.387M
December 31, 2016	1.906M
September 30, 2016	1.477M
June 30, 2016	1.098M
March 31, 2016	7.83M
December 31, 2015	1.336M
September 30, 2015	3.731M
June 30, 2015	1.326M
March 31, 2015	2.320M
December 31, 2014	0.671M
September 30, 2014	0.556M
June 30, 2014	0.797M
March 31, 2014	0.469M
December 31, 2013	0.69M
September 30, 2013	0.545M
June 30, 2013	0.639M
March 31, 2013	1.573M
December 31, 2012	0.799M
September 30, 2012	0.572M
June 30, 2012	0.619M
March 31, 2012	1.428M
December 31, 2011	0.907M
September 30, 2011	0.8946M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.146M

Minimum

Sep 2019

4.792M

Maximum

Jun 2022

2.713M

Average

2.978M

Median

Jun 2023

SG&A Expense (Quarterly) Benchmarks